---
figid: PMC9298327__NAN-48-0-g001
figtitle: Expression, prognostic significance and therapeutic implications of PD‐L1
  in gliomas
organisms:
- NA
pmcid: PMC9298327
filename: NAN-48-0-g001.jpg
figlink: /pmc/articles/PMC9298327/figure/nan12767-fig-0001/
number: F1
caption: 'Mechanisms of immune evasion mediated by the PD‐1/PD‐L1 signalling pathway.
  PD‐1/PD‐L1 interaction in the immunosuppressive tumour micro‐environment of gliomas
  leads to decreased proliferation and exhaustion of effector T‐cells as well as decreased
  cytokine production, providing the tumour cell with survival benefits. Blocking
  the PD‐1/PD‐L1 pathway with anti‐PD‐1 or anti‐PD‐L1 monoclonal antibodies leads
  to differentiation of effector T‐cells by stimulating the PI3K/Akt or Ras/MAPK pathways
  and suppression of T‐reg differentiation, which ultimately enhances anti‐tumour
  immunity. Abbreviations: PD‐L1 Programmed death‐ligand 1, PD‐1 Programmed death‐1,
  GAL‐9 Galectin 9, TIM‐3 T‐cell immunoglobulin mucin‐3, LAG‐3 Lymphocyte‐activation
  gene 3, TCR T‐cell receptor, MHC Major histocompatibility complex, APC Antigen presenting
  cell, CD Cluster of differentiation, T‐reg Regulatory T‐cell, IL Interleukin, VEGF
  Vascular endothelial growth factor, TGF Transforming growth factor. Created with
  BioRender.com'
papertitle: Expression, prognostic significance and therapeutic implications of PD‐L1
  in gliomas.
reftext: Gayaththri Vimalathas, et al. Neuropathol Appl Neurobiol. 2022 Feb;48(1):e12767.
year: '2022'
doi: 10.1111/nan.12767
journal_title: Neuropathology and Applied Neurobiology
journal_nlm_ta: Neuropathol Appl Neurobiol
publisher_name: John Wiley and Sons Inc.
keywords: biomarker | checkpoint inhibition | glioma | glioblastoma multiforme | immunotherapy
  | PD‐L1 | prognosis | programmed death‐ligand 1
automl_pathway: 0.9577892
figid_alias: PMC9298327__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC9298327__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9298327__NAN-48-0-g001.html
  '@type': Dataset
  description: 'Mechanisms of immune evasion mediated by the PD‐1/PD‐L1 signalling
    pathway. PD‐1/PD‐L1 interaction in the immunosuppressive tumour micro‐environment
    of gliomas leads to decreased proliferation and exhaustion of effector T‐cells
    as well as decreased cytokine production, providing the tumour cell with survival
    benefits. Blocking the PD‐1/PD‐L1 pathway with anti‐PD‐1 or anti‐PD‐L1 monoclonal
    antibodies leads to differentiation of effector T‐cells by stimulating the PI3K/Akt
    or Ras/MAPK pathways and suppression of T‐reg differentiation, which ultimately
    enhances anti‐tumour immunity. Abbreviations: PD‐L1 Programmed death‐ligand 1,
    PD‐1 Programmed death‐1, GAL‐9 Galectin 9, TIM‐3 T‐cell immunoglobulin mucin‐3,
    LAG‐3 Lymphocyte‐activation gene 3, TCR T‐cell receptor, MHC Major histocompatibility
    complex, APC Antigen presenting cell, CD Cluster of differentiation, T‐reg Regulatory
    T‐cell, IL Interleukin, VEGF Vascular endothelial growth factor, TGF Transforming
    growth factor. Created with BioRender.com'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CD274
  - HAVCR2
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - KRAS
  - HRAS
  - NRAS
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - CD28
  - CTLA4
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTPN11
  - LAG3
  - PTEN
  - ZAP70
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - HLA-C
  - CD80
  - CD86
  - IL10
  - IL6
  - IL4
  - TGFB1
  - TGFB2
  - TGFB3
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - APC
  - PROC
  - ras
  - Ras64B
  - Ras85D
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - csw
  - Pten
  - Tcr
  - Mhc
  - zip
  - dpp
  - gbb
  - put
  - mav
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
---
